These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 8996042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS, Lee TJ, Kim J, Kim D.
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A.
    Cancer; 2000 Oct 01; 89(7):1611-25. PubMed ID: 11013378
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
    Barbaro G, Barbarini G, Di Lorenzo G.
    Endoscopy; 1995 Jun 01; 27(5):377-83. PubMed ID: 7588352
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The incidence, etiology and clinical significance of visceral mycoses in patients with AIDS].
    Manfredi R, Nanetti A, Mazzoni A, Mastroianni A, Chiodo F.
    Minerva Med; 1993 Jun 01; 84(7-8):383-91. PubMed ID: 8414130
    [Abstract] [Full Text] [Related]

  • 12. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.
    Clin Infect Dis; 2008 Nov 15; 47(10):1270-6. PubMed ID: 18840077
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G, Di Lorenzo G.
    Ital J Gastroenterol; 1995 May 15; 27(4):175-80. PubMed ID: 8520033
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA, Gomirato G.
    Pediatrics; 2006 Jan 15; 117(1):e22-32. PubMed ID: 16326690
    [Abstract] [Full Text] [Related]

  • 20. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, Goldman M, Thomas CJ, Gutsch HM, Moskovitz B, Dismukes WE, Kauffman CA.
    Clin Infect Dis; 1999 May 15; 28(5):1049-56. PubMed ID: 10452633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.